Sanofi Pasteur said that the Panenza is produced in the same way as traditional vaccines against seasonal influenza. In these circumstances it is Sanofi Pasteur.jpgétonnant there was no authorization field, while the firms competing vaccines (Pandemrix Focetria then CELVAPAN) were authorized in September and October. Our health authorities insecurity have given unilateral authority to the vaccine.
Sanofi argues that Panenza is not identical to Fluzone, its seasonal flu vaccine produced in the United States, and used against influenza A, after modification of the antigen. Why Sanofi-n he not made the Fluzone for Europe too? Why the firm did considerable delays in providing the Panenza, while the A H1N1 version Fluzone was approved by the U.S. Drug Administration (FDA) in mid-September?
For this vaccine even less tested than others, the laboratory itself told its shareholders not to get carried away, it may be that the reality differs from promises ... And some examples of misinformation by Sanofi recently n'accréditent still nothing in the credibility of the firm. Anyway, it's science and public health that it should be, therefore, evidence, not words.
Bilingual speech on Sanofi flu vaccine Panenza enough trouble
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment